These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1805233)

  • 1. Psychopharmacological effects of MK-801 in infant and preweanling rat pups.
    Rajachandran L; Goodwin GA; Spear LP
    Pharmacol Biochem Behav; 1991 Oct; 40(2):291-5. PubMed ID: 1805233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in preweanling rat pups.
    Frambes NA; Kirstein CL; Moody CA; Spear LP
    Eur J Pharmacol; 1990 Jun; 182(1):9-17. PubMed ID: 2144825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral analysis of the electroencephalogram in neonatal rats chronically treated with the NMDA antagonist MK-801.
    Gorter JA; Veerman M; Mirmiran M; Bos NP; Corner MA
    Brain Res Dev Brain Res; 1991 Dec; 64(1-2):37-41. PubMed ID: 1786646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of the 5-HT1A receptor agonist 8-OH-DPAT increase ingestive behavior in late preweanling and postweanling, but not neonatal rat pups.
    Spear LP; Frambes NA; Goodwin G
    Eur J Pharmacol; 1991 Oct; 203(1):9-15. PubMed ID: 1839148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of MK-801 in morphine-dependent and non-dependent mice.
    Belozertseva I; Zvartau E; Bespalov A
    Life Sci; 1996; 58(4):PL55-61. PubMed ID: 8538362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.
    McDonald JW; Silverstein FS; Cardona D; Hudson C; Chen R; Johnston MV
    Neuroscience; 1990; 36(3):589-99. PubMed ID: 2234402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical effects of very low dose MK-801.
    Tang Y; Zou H; Strong JA; Cui Y; Xie Q; Zhao G; Jin M; Yu L
    Eur J Pharmacol; 2006 May; 537(1-3):77-84. PubMed ID: 16626696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quipazine-induced behavior in neonatal rat pups.
    Spear LP; Ristine LA
    Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats.
    Scalzo FM; Burge LJ
    Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats.
    Marco LA; Joshi RS; Chronister RB
    Psychopharmacology (Berl); 1991; 103(4):462-6. PubMed ID: 1676526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats.
    Lehmann-Masten VD; Geyer MA
    Neuropharmacology; 1991 Jun; 30(6):629-36. PubMed ID: 1922682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course effects of MK-801: the relationship between brain neurochemistry and behavior.
    Dai H; Gebhardt K; Carey RJ
    Brain Res Bull; 1995; 36(2):175-80. PubMed ID: 7534612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK-801 prevents the development of behavioral sensitization during repeated morphine administration.
    Jeziorski M; White FJ; Wolf ME
    Synapse; 1994 Feb; 16(2):137-47. PubMed ID: 8197575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate and long-term effects of neonatal MK-801 treatment on nonspatial learning.
    Griesbach GS; Amsel A
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11435-9. PubMed ID: 9736754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats.
    Löscher W; Hönack D; Fassbender CP
    Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in neonatal rat pups.
    Kirstein CL; Spear LP
    Eur J Pharmacol; 1988 Jun; 150(3):339-45. PubMed ID: 2970973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits.
    Thomas JD; Weinert SP; Sharif S; Riley EP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1218-25. PubMed ID: 9347082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired working memory by repeated neonatal MK-801 treatment is ameliorated by galantamine in adult rats.
    Su YA; Huang RH; Wang XD; Li JT; Si TM
    Eur J Pharmacol; 2014 Feb; 725():32-9. PubMed ID: 24440172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of MK-801 on body temperature and behavior in the rat: cross-sensitization and cross-tolerance with phencyclidine.
    Pechnick RN; Hiramatsu M
    Eur J Pharmacol; 1994 Jan; 252(1):35-42. PubMed ID: 8149994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.